Literature DB >> 5564399

Biochemical and genetic studies in cystinuria: observations on double heterozygotes of genotype I-II.

C L Morin, M W Thompson, S H Jackson, A Sass-Kortsak.   

Abstract

10 families with cystinuria were investigated by measuring: (a) quantitative 24 hr urinary excretion of amino acids by column chromatography; (b) endogenous renal clearances of amino acids and creatinine; (c) intestinal uptake of (34)C-labeled L-cystine, L-lysine, and L-arginine using jejunal mucosal biopsies; (d) oral cystine loading tests. All four of these were studied in the probands and the first two in a large number of the family members.49 members of 8 families were found to have a regular genetic pattern as described previously by Harris, Rosenberg, and their coworkers. Clinical or biochemical differences between the homozygotes type I (recessive cystinuria) and homozygotes type II (incompletely recessive cystinuria) have not been found. Both types excreted similarly excessive amounts of cystine, lysine, arginine, and ornithine, and had high endogenous renal clearances for these four amino acids. Some homozygotes of both types had a cystine clearance higher than the glomerular filtration rate. Jejunal mucosa from both types of homozygotes exhibited near complete inability to concentrate cystine and lysine in vitro. This was also documented in vivo with oral cystine loads. The heterozygotes type I were phenotypically normal with respect to the above four measurements. The heterozygotes type II showed moderate but definite abnormalities in their urinary excretion and their renal clearances of dibasic amino acids. Of the four amino acids concerned, cystine was the most reliable marker to differentiate between the heterozygotes type II and the homozygous normals. In this study, type III cystinuria, as described by Rosenberg, was not encountered. In two additional families, double heterozygotes of genotype I/II were found. The disease affecting these is clinically and biochemically less severe than that affecting homozygotes of either type I or type II. With respect to the four parameters used in this study, the double heterozygotes type I/II have results which are intermediate between those of the homozygotes type I and II and those of the heterozygotes type II.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5564399      PMCID: PMC292122          DOI: 10.1172/JCI106688

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  A modified procedure for the automatic analysis of amino acids.

Authors:  K A PIEZ; L MORRIS
Journal:  Anal Biochem       Date:  1960-11       Impact factor: 3.365

2.  Studies on the urinary excretion of oxalate by normal subjects.

Authors:  H E ARCHER; A E DORMER; E F SCOWEN; R W WATTS
Journal:  Clin Sci       Date:  1957-08       Impact factor: 6.124

3.  A modified carbonate-phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method.

Authors:  R J HENRY; C SOBEL; J KIM
Journal:  Am J Clin Pathol       Date:  1957-08       Impact factor: 2.493

4.  The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin.

Authors:  A HODGKINSON; L N PYRAH
Journal:  Br J Surg       Date:  1958-07       Impact factor: 6.939

5.  Amino acid clearances in cystinuria.

Authors:  V K ARROW; R G WESTALL
Journal:  J Physiol       Date:  1958-06-18       Impact factor: 5.182

6.  Endogenous renal clearance rates of free amino acids in pre-pubertal children. (Employing an accelerated procedure for elution chromatography of basic amino acids on ion exchange resin).

Authors:  C R Scriver; E Davies
Journal:  Pediatrics       Date:  1965-10       Impact factor: 7.124

7.  Heterozygotes for cystinuria.

Authors:  J C Crawhall; E P Saunders; C J Thompson
Journal:  Ann Hum Genet       Date:  1966-03       Impact factor: 1.670

8.  Cystinuria: biochemical evidence for three genetically distinct diseases.

Authors:  L E Rosenberg; S Downing; J L Durant; S Segal
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

9.  Genetic heterogeneity in cystinuria: evidence for allelism.

Authors:  L E Rosenberg; J L Durant; I Albrecht
Journal:  Trans Assoc Am Physicians       Date:  1966

10.  Urinary excretion of free amino acids in normal adult men and women.

Authors:  P SOUPART
Journal:  Clin Chim Acta       Date:  1959-03       Impact factor: 3.786

View more
  7 in total

1.  Cystinuric heterozygotes and cystine-loading.

Authors:  R Minami; K Olek; P Wardenbach
Journal:  Humangenetik       Date:  1975-09-10

2.  Balanced translocation (14;20) in a mentally handicapped child with cystinuria.

Authors:  M Sharland; M Jones; M Bain; R Chalmers; J Hammond; M A Patton
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

3.  Pilot screening programme for cystinuria in the Valencian community.

Authors:  M L Cabello-Tomás; A M García-Gómez; M L Guillén-Domínguez
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

4.  Renal transport of lysine and arginine in lysinuric protein intolerance.

Authors:  T Kato; N Mizutani; M Ban
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

5.  Transport of L-cystine in isolated perfused proximal straight tubules.

Authors:  J A Schafer; M L Watkins
Journal:  Pflugers Arch       Date:  1984-06       Impact factor: 3.657

6.  Cystine crystalluria and urinary saturation in cystine and non-cystine stone formers.

Authors:  M Labeeuw; C Gerbaulet; N Pozet; P Zech; J Traeger
Journal:  Urol Res       Date:  1981

7.  Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition.

Authors:  Alexander Muir; Laura V Danai; Dan Y Gui; Chiara Y Waingarten; Caroline A Lewis; Matthew G Vander Heiden
Journal:  Elife       Date:  2017-08-15       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.